Prevention and treatment of ischaemic heart disease are both important in patients with chronic kidney disease

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.25, Iss.6, 2009-06, pp. : 19-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Ischemic Heart Disease in Patients with Chronic Kidney Disease

By Mutwali Arif

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 4, 2008-01 ,pp. : 219-231

Adis International

Access to resources Recommend Favorite

Calcium antagonists in the treatment of hypertension in patients with ischaemic heart disease

By Rosendorff Clive

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1535-1541

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease

By Scheen André J

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 5, 2013-05 ,pp. : 529-550

Informa Healthcare

Access to resources Recommend Favorite

Indoxyl Sulfate: A Candidate Target for the Prevention and Treatment of Cardiovascular Disease in Chronic Kidney Disease

Current Drug Targets, Vol. 16, Iss. 4, 2015-04 ,pp. : 366-372

Bentham Science Publishers

Access to resources Recommend Favorite

Stage of chronic kidney disease and severity of coronary heart disease manifestation

By Athyros Vasilios G Katsiki Niki Karagiannis Asterios Mikhailidis Dimitri P

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 457-460

Informa Healthcare

Access to resources Recommend Favorite